Clinical Trial Update: The Risk of Uncomplicated Peptic Ulcer in a Cohort of Secondary Prevention Aspirin Users

View source ↗

Summary

The trial update reports on the risk of developing uncomplicated peptic ulcer in a cohort of aspirin users for secondary prevention. The study was sponsored by …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcer Disease

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: AstraZeneca | Conditions: Uncomplicated Peptic Ulcer | Status: COMPLETED